These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1304218

  • 1. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M, Esser P, Heimann K, Wiedemann P.
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [Abstract] [Full Text] [Related]

  • 2. Retinal microglia: a new cell in idiopathic proliferative vitreoretinopathy?
    Weller M, Esser P, Heimann K, Wiedemann P.
    Exp Eye Res; 1991 Aug; 53(2):275-81. PubMed ID: 1915683
    [Abstract] [Full Text] [Related]

  • 3. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [Abstract] [Full Text] [Related]

  • 4. [Thrombospondin and its importance in proliferative retinal diseases].
    Esser P, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1991 Aug; 88(4):337-40. PubMed ID: 1786916
    [Abstract] [Full Text] [Related]

  • 5. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C, Harada T, Mitamura Y, Quah HM, Ohtsuka K, Kotake S, Ohno S, Wada K, Takeuchi S, Tanaka K.
    Mol Vis; 2004 Jan 15; 10():31-6. PubMed ID: 14737065
    [Abstract] [Full Text] [Related]

  • 6. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
    Bresgen M, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Jan 15; 87(3):279-82. PubMed ID: 2198204
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
    Tsanou E, Ioachim E, Stefaniotou M, Gorezis S, Charalabopoulos K, Bagli H, Peschos D, Psilas K, Agnantis NJ.
    Int J Clin Pract; 2005 Oct 15; 59(10):1157-61. PubMed ID: 16178982
    [Abstract] [Full Text] [Related]

  • 8. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
    Esser P, Bresgen M, Fischbach R, Heimann K, Wiedemann P.
    Ger J Ophthalmol; 1995 Sep 15; 4(5):269-74. PubMed ID: 7496336
    [Abstract] [Full Text] [Related]

  • 9. Glial cells in culture of preretinal membrane of proliferative vitreoretinopathy.
    Yamashita H, Hori S, Kitano S, Ishii Y, Masuda K.
    Jpn J Ophthalmol; 1985 Sep 15; 29(1):42-53. PubMed ID: 3892106
    [Abstract] [Full Text] [Related]

  • 10. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M, Tenckhoff S, Jahn K, Iandiev I, Biedermann B, Schnurrbusch UE, Limb GA, Reichenbach A, Wolf S, Wiedemann P, Kohen L, Bringmann A.
    Mol Vis; 2005 Jun 10; 11():397-413. PubMed ID: 15988409
    [Abstract] [Full Text] [Related]

  • 11. Mononuclear phagocytes in proliferative vitreoretinopathy (PVR). A specific role of microglial cells in non-traumatic disease?
    Weller M, Esser P, Heimann K, Wiedemann P.
    Eur J Ophthalmol; 1991 Jun 10; 1(4):161-6. PubMed ID: 1821209
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.
    Exp Eye Res; 1997 Sep 10; 65(3):365-78. PubMed ID: 9299173
    [Abstract] [Full Text] [Related]

  • 13. Cellular components of proliferative vitreoretinal membranes.
    Kwak SI, Chung H, Lee J.
    Korean J Ophthalmol; 1991 Dec 10; 5(2):68-75. PubMed ID: 1812289
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May 10; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 15. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
    Heidenkummer HP, Kampik A.
    Fortschr Ophthalmol; 1991 May 10; 88(3):219-24. PubMed ID: 1889766
    [Abstract] [Full Text] [Related]

  • 16. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep 10; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 17. [Contractile elements in proliferative retinal diseases].
    Molitor R, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb 10; 89(1):34-8. PubMed ID: 1581690
    [Abstract] [Full Text] [Related]

  • 18. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M, Esser P, Wiedemann P, Heimann K.
    Ger J Ophthalmol; 1993 Feb 10; 2(1):28-31. PubMed ID: 7679595
    [Abstract] [Full Text] [Related]

  • 19. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP, Kampik A.
    Ger J Ophthalmol; 1992 Feb 10; 1(3-4):170-5. PubMed ID: 1483131
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1989 Feb 10; 86(2):121-3. PubMed ID: 2661370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.